All In Biotech

Drug Trial Radar · NCT06629779

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF PF-06821497 (MEVROMETOSTAT) WITH ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MEVPRO-2)

Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 900 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

900

Planned (sponsor's estimate)

Start

Oct 22, 2024

Primary completion

Sep 30, 2027

Study completion Nov 30, 2028

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Oct 8, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, care provider)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will explore whether a combination of the investigational drug PF-06821497 and enzalutamide will work better than taking enzalutamide alone in participants with mCRPC who are ARSi or abiraterone naïve.

Conditions

  • Metastatic Castration-Resistant Prostate Cancer

Interventions

  • PF-06821497Drug

    Oral continuous

  • PlaceboDrug

    Oral continuous

  • EnzalutamideDrug

    Oral continuous

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Radiographic Progression Free Survival (rPFS)Time frame: Randomization up to approximately 3 years

Locations

203 sites in 26 countries. Site status is shown where the registry gives one.

  • Ironwood Cancer & Research Centers

    Chandler, Arizona

  • Ironwood Cancer & Research Centers

    Gilbert, Arizona

  • Palo Verde Hematology Oncology

    Glendale, Arizona

  • Ironwood Cancer & Research Centers

    Glendale, Arizona

  • Ironwood Cancer & Research Centers

    Goodyear, Arizona

  • Ironwood Cancer & Research Centers

    Mesa, Arizona

  • Ironwood Cancer & Research Centers

    Mesa, Arizona

  • Ironwood Cancer & Research Centers

    Phoenix, Arizona

  • Ironwood Cancer & Research Centers

    Scottsdale, Arizona

  • Highlands Oncology

    Fayetteville, Arkansas

  • Highlands Oncology

    Rogers, Arkansas

  • Highlands Oncology Group

    Springdale, Arkansas

  • Los Angeles Cancer Network (LACN)

    Anaheim, California

  • Los Angeles Cancer Network (LACN)

    Fountain Valley, California

  • Los Angeles Cancer Network (LACN)

    Glendale, California

  • Los Angeles Cancer Network (LACN)

    Glendale, California

  • Los Angeles Cancer Network (LACN)

    Laguna Hills, California

  • Los Angeles Cancer Network (LACN)

    Los Angeles, California

  • Los Angeles Cancer Network (LACN)

    Los Angeles, California

  • Blessing Hospital

    Quincy, Illinois

  • Blessing Physician Services

    Quincy, Illinois

  • Montefiore Medical Center - Medical Park

    The Bronx, New York

  • Montefiore Medical Center

    The Bronx, New York

  • Harborview Medical Center

    Seattle, Washington

  • Fred Hutchinson Cancer Center

    Seattle, Washington

  • University of Washington Medical Center - Montlake

    Seattle, Washington

  • IMAXE

    Buenos Aires, Argentina

  • Centro Medico Fleischer

    Buenos Aires, Argentina

  • Hospital Privado Centro Médico de Córdoba

    Córdoba, Argentina

  • Centro de Urología (CDU)

    CABA, Buenos Aires, Argentina

  • Hospital Sirio Libanes

    Capital Federal, Buenos Aires, Argentina

  • Imagenes Mdq

    Mar del Plata, Buenos Aires, Argentina

  • Instituto de Investigaciones Clínicas Mar del Plata

    Mar del Plata, Buenos Aires, Argentina

  • Centro Medico Privado CEMAIC

    Capital, Córdoba Province, Argentina

  • Instituto do Cancer Arnaldo Vieira de Carvalho

    São Paulo, Brazil

  • IBCC - Núcleo de Pesquisa e Ensino

    São Paulo, Brazil

  • Crio - Centro Regional Integrado de Oncologia

    Fortaleza, Ceará, Brazil

  • Instituto D'Or de Pesquisa e Ensino (IDOR) - Filial Salvador

    Salvador, Estado de Bahia, Brazil

  • Clinica Amo - Rio Vermelho

    Salvador, Estado de Bahia, Brazil

  • Clinica Amo - Rio Vermelho

    Salvador, Estado de Bahia, Brazil

Showing 40 of 203 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.